Log in to save to my catalogue

Cancer combination therapies by angiogenesis inhibitors; a comprehensive review

Cancer combination therapies by angiogenesis inhibitors; a comprehensive review

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_54b9ab4488744e86b8ec35814ea2f588

Cancer combination therapies by angiogenesis inhibitors; a comprehensive review

About this item

Full title

Cancer combination therapies by angiogenesis inhibitors; a comprehensive review

Publisher

England: BioMed Central

Journal title

Cell communication and signaling, 2022-04, Vol.20 (1), p.49-49, Article 49

Language

English

Formats

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

Abnormal vasculature is one of the most conspicuous traits of tumor tissue, largely contributing to tumor immune evasion. The deregulation mainly arises from the potentiated pro-angiogenic factors secretion and can also target immune cells' biological events, such as migration and activation. Owing to this fact, angiogenesis blockade therapy was es...

Alternative Titles

Full title

Cancer combination therapies by angiogenesis inhibitors; a comprehensive review

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_54b9ab4488744e86b8ec35814ea2f588

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_54b9ab4488744e86b8ec35814ea2f588

Other Identifiers

ISSN

1478-811X

E-ISSN

1478-811X

DOI

10.1186/s12964-022-00838-y

How to access this item